韩国儿童及年轻成人甲状腺癌放射性碘治疗:基于人群研究
结果显示51.3%接受至少1次RAIT,RAIT频率及高剂量比例均下降,RAIT队列第二原发癌风险升高(校正HR 1.52,95%CI 1.03—2.24,P=0.035)。
要点
- 儿童及年轻成人甲状腺癌术后RAIT比例及高剂量比例在研究期间显著下降。
- RAIT与第二原发癌风险升高相关(校正HR 1.52,95%CI 1.03—2.24)。
- 儿童及年轻成人甲状腺癌幸存者需关注RAIT相关第二原发癌风险。
核心结论
- 儿童及年轻成人甲状腺癌术后RAIT比例及剂量在研究期间显著下降,但RAIT与第二原发癌风险升高相关。
主要发现
- 9548例(51.3%)接受至少1次RAIT,初始剂量为4.35±2.19 GBq。
- RAIT总体频率从60.9%降至38.5%,高剂量RAIT(>3.7 GBq)频率从64.2%降至36.5%。
- RAIT队列第二原发癌风险升高,校正HR 1.52(95%CI 1.03—2.24),P=0.035。
关键数值与推荐
- RAIT与第二原发癌风险升高相关:校正HR 1.52(95%CI 1.03—2.24),P=0.035。
- 高剂量RAIT定义为>3.7 GBq。
临床怎么用
- 对儿童及年轻成人甲状腺癌患者决策RAIT时,应权衡获益与第二原发癌风险。
- 随访中需关注第二原发癌的监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated radioactive iodine treatment (RAIT) patterns and the secondary cancer incidence among children and young adults receiving RAIT after thyroidectomy for thyroid cancer. METHODS: This population-based cohort study used the Health Insurance Review and Assessment database of South Korea to identify a total of 18 617 children and young adults (0-29 years) who underwent thyroidectomy for thyroid cancer between 2008 and 2018. We recorded age at surgery, sex, the interval from surgery to RAIT, the doses of RAI, the number of RAIT sessions, and secondary cancer incidence. RESULTS: A total of 9548 (51.3%) children and young adults underwent 1 or more RAIT sessions. The initial dose of RAIT was 4.35 ± 2.19 GBq. The overall RAIT frequency fell from 60.9% to 38.5%, and the frequency of high-dose RAIT (>3.7 GBq) fell from 64.2% to 36.5% during the observational period. A total of 124 cases of secondary cancer developed during 120 474 person-years of follow-up; 43 (0.5%) in the surgery cohort and 81 (0.8%) in the RAIT cohort. Thus, the RAIT cohort was at an increased risk of secondary cancer (adjusted hazard ratio 1.52 [95% confidence interval 1.03-2.24], P = 0.035). CONCLUSION: The proportion of children and young adults receiving RAIT, and the RAI dose, fell significantly over the observational period. RAIT was associated with secondary cancers. This is of major concern in the context of child and young adult thyroid cancer survivors.
引用
- Seo GH, Kong KA, Kim BS, et al. Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study. J Clin Endocrinol Metab. 2021. PMID: 33755732. doi:10.1210/clinem/dgab192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。